{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-047516","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.992298+00:00","generated_at":"2026-06-10T02:09:16.611184+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SANUWAVE Health prelim Q3 revenue $4.7-4.9M, up 13-18% YoY","bullets":["Preliminary Q3 2023 revenue range $4.7M to $4.9M, representing 13-18% growth over Q3 2022.","UltraMist product line revenue increased >25% YoY and >10% sequentially vs Q2 2023.","UltraMist accounted for >90% of total revenue in the quarter.","Production constraints easing contributed to revenue growth; full Q3 results expected mid-November.","No other financial metrics (EPS, net income) disclosed; numbers remain preliminary."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-047516","json":"https://secwatch.observer/filing/0001140361-23-047516.json","markdown":"https://secwatch.observer/filing/0001140361-23-047516.md","text":"https://secwatch.observer/filing/0001140361-23-047516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123047516/0001140361-23-047516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123047516/ef20012207_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:09:16.611184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"67008cb9f1155627d0b42cad59f4c359c8a0db8c","claim":"SANUWAVE Health, Inc. reported third quarter ended September 30, 2023 results: revenue $4.7 million to $4.9 million.","evidence_excerpt":"99.1 Exhibit 99.1 SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023 SANUWAVE is pleased to announce preliminary revenues of $4.7 million to $4.9 million for the third quarter ended September 30, 2023 Results indicate 13-18% growth rate over Q3 2022 UltraMist revenues (systems and consumables) increased in excess","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123047516/0001140361-23-047516-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$4.7 million to $4.9 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}